Journal of Cancer Research and Therapeutics Close
 

Figure 1: Receiver operating curve for determining the optimal cutoff value in in identifying patients with advanced tumor–node–metastasis stage for neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio

Figure 1: Receiver operating curve for determining the optimal cutoff value in in identifying patients with advanced tumor–node–metastasis stage for neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio